The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 randomized, double-blind, placebo-controlled trial of endocrine therapy ± radium-223 dichloride (Ra-223) in HER2- hormone receptor+ breast cancer patients with bone metastases.
 
Robert E. Coleman
Research Funding - Bayer (Inst)
Expert Testimony - Novartis
 
Rui Li
Employment - Bayer
 
Amrita G. Sawhney
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Oana Petrenciuc
Employment - Bayer
Travel, Accommodations, Expenses - Bayer
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech